BioSpace News Archive

Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology

Oculis announces the appointments of Fabio Baschiera PharmD, MPh, Ph.D. as Vice President of Clinical Development, and Louie-Anne Gauthier M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing.

Auris Medical Holding AG today announced the results of its pre-Investigational New Drug (pre-IND) meeting with the United States Food & Drug Administration (FDA), where the FDA addressed the Company’s questions and provided guidance on its AM-201 program with intranasal betahistine for the prevention of olanzapine-induced weight gain.

Three oral presentations highlighted analyses from the PEPITES Phase III study

Roivant Sciences teamed with Cincinnati Children’s Hospital Medical Center to launch Aruvant Sciences. Roivant is the umbrella company run by Vivek Ramaswamy, which has launched a number of companies with “vant” in the names.

Vertex Pharmaceuticals announced that two Phase III clinical trials of its triple combination of VX-659, tezacaftor and ivacaftor met their primary endpoint in cystic fibrosis (CF).

As more and more western pharmaceutical companies are pouring money into China, it’s only natural that there is a bit of western “brain drain” as well. A recent NPR report highlighted a number of U.S.-based scientists who have sought career advancement in China.

Clinical trial authorizations received in all 6 participating countries

Medigene AG today announced its participation at the following upcoming investor and scientific conferences

Asceneuron SA announced today it has commenced a new clinical trial of its lead asset, ASN120290.